Bulletin: ...WINTER WEATHER ADVISORY REMAINS IN EFFECT UNTIL 7 AM EST WEDNESDAY... * WHAT...Snow. Additional snow accumulations between 1 and 3 inches. * WHERE ...

Former Soccer AM host Tim Lovejoy has revealed he's been accused of "woke nonsense" for his comments on the show's 'Soccerette' feature. Lovejoy spent a decade at the helm of the Saturday morning ...

Detroit Mercy Titans (8-18, 4-11 Horizon League) at Oakland Golden Grizzlies (11-15, 8-7 Horizon League) Auburn Hills, Michigan; Sunday, 3 p.m. EST BOTTOM LINE: Detroit Mercy visits Oakland after ...

Bess Lovejoy is a writer and editor who lives in Brooklyn. She is the author of Rest in Pieces: The Curious Fates of Famous Corpses. Tasked with curbing a 1907 outbreak, Esther Pohl emphasized the ...

Doctors and their patients discuss the range of services that Duke Cancer Institute provides to teens and younger adults with a history of cancer. Beyond Cancer: Mental Health and Therapy Duke ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Duke University and Duke-NUS Medical School are proud to announce the recipients of their latest Research Collaboration Pilot Project grants, totalling more than S$1 million. Who hasn't been there?

The Greater Middle East is home to a rich genetic diversity that remains largely untapped in genomic research. This Perspective explores its potential for rare disease research, obstacles limiting ...

Allen David Mukeba Jr. is averaging 13.8 points and 8.5 rebounds over the last 10 games. Lovejoy is averaging 16.3 points, 3.8 assists and 1.9 steals for the Titans. TJ Nadeau is averaging 10.2 points ...

Feb. 18, 2025 — The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study ...

After hours: February 14 at 4:06:13 PM EST Loading Chart for SBSI ...

Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions remain.